MEDS

1.34084.14%
PP

Prashant Patel

Interim Co-CEO, President & Director

Mr. Prashant Patel, R.Ph., M.Sc., is Chief Executive Officer and Chairman of Crown Reserve Acquisition Corp. I from April 2025. Mr. Patel serves as President of Wellgistics Health, Inc since October 2, 2025 and was its Interim-CEO since October 3, 2025 and is its Interim Co-CEO and Director since 2022. He was Chief Strategy Officer and Vice Chairman of the Board of DataMEDS AI, Inc. (formerly known as Wellgistics Health, Inc.) (f/k/a Danam Health, Inc.) and had been its Director since 2022 until August 8, 2025. Mr. Patel served as a director and president of TRxADE Health, Inc. from 2014 to June 2024. Mr. Patel serves on the board of Eulogistic Health Inc. He Founded of TRxADE HEALTH, Inc. (formerly known as Trxade Group, Inc.) He was President, COO at Trxade, Inc & served as Director at Trxade, Inc until January 16, 2025. He has been President and Chief Operating Officer at TRxADE HEALTH, Inc. (formerly known as Trxade Group, Inc.) since January 8, 2014 and serves as its Interim Chief Finance Officer. He is Interim Principal Financial and Accounting Officer of TRxADE HEALTH, Inc. from March 6, 2023. Mr. Patel was Chief Operating Officer and President of Trxade Nevada since August 2010. Mr. Patel also serves as a director, the President and the Chief Operating Officer of Danam Health, Inc. Mr. Patel is a registered pharmacist and pharmaceutical consultant with experience in retail pharmacy and pharmaceutical logistics and the founder of several pharmacies in the Tampa Bay area, FL. Mr. Patel had been the President of Trxade since August 2010. Since October 2008, Mr. Patel also founded and operated Tampa Bay Pharmacy and Apaa LLC, community pharmacies, between 2008 and 2014. Mr. Patel has been Managing Member of the APAA LLC. Si.nce April 2007, Mr. Patel has been a Vice President of Holiday Pharmacy, Inc. He was Director at Sceinture Holdings Inc from June 2023 to May 2025. He had been a Director at TRxADE HEALTH, Inc. (formerly known as Trxade Group, Inc.) since January 8, 2014. Mr. Patel has been a board advisor to several special purpose acquisition companies over the years including Oceantech Acquisitions I Corp, Powerup Acquisitions Corp and Aesther Healthcare Acquisitions Corp. He was President and Chief Operating Officer of Scienture Holdings, Inc since January 8, 2014 until 2025 and was its Interim Principal Financial and Accounting Officer since March 2023 until March 13, 2025 and had been its Director since January 8, 2014. Mr. Patel also served as a director, the President and the Chief Operating Officer of DataMEDS AI, Inc. (formerly known as Wellgistics Health, Inc.) He completed Bpharm from the University of Nottingham/UK and completed MSC in Transport, Trade & Finance from Cass Business School (Formerly known as Bayes Business School), City University, UK.

Positions